New England Biolabs

NEBNext Multiplex Oligos Set 1 for Illumina (96 UDIs)

#E6440S · ngs library prep

43
Citing papers
482
Combined citations
Supplier page Find this product

Research areas

Genomics and Chromatin Dynamics5CRISPR and Genetic Engineering4Epigenetics and DNA Methylation4RNA modifications and cancer4Chromatin Remodeling and Cancer3Pluripotent Stem Cells Research3Genomics and Phylogenetic Studies3interferon and immune responses3

Papers citing this product

1
Dual-specificity RNA aptamers enable manipulation of target-specific O-GlcNAcylation and unveil functions of O-GlcNAc on β-catenin
Cell·2023·107 cit.·DOI
2
Micronuclei-based model system reveals functional consequences of chromothripsis in human cells
eLife·2019·106 cit.·DOI
3
Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies
bioRxiv (Cold Spring Harbor Laboratory)·2020·31 cit.·DOI
4
Acute MeCP2 loss in adult mice reveals transcriptional and chromatin changes that precede neurological dysfunction and inform pathogenesis
Neuron·2024·24 cit.·DOI
5
Evolution of Spatial and Temporal<i>cis-</i>Regulatory Divergence in Sticklebacks
Molecular Biology and Evolution·2023·19 cit.·DOI
6
Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung
Respiratory Research·2021·19 cit.·DOI
7
Molecular Signature of <sup>18</sup>F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study
Journal of Nuclear Medicine·2022·19 cit.·DOI
8
Long non-coding RNAs direct the SWI/SNF complex to cell type-specific enhancers
Nature Communications·2025·18 cit.·DOI
9
Ccr2+ Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i> -Mutant Melanoma
Cancer Research·2023·17 cit.·DOI
10
Enhanced RNA-targeting CRISPR-Cas technology in zebrafish
Nature Communications·2025·16 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.